{"symbol": "NBRV", "companyName": "Nabriva Therapeutics plc", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.nabriva.com", "description": "Nabriva Therapeutics AG is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.", "CEO": "Theodore R. Schroeder", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}